Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
9 Articles
9 Articles
Genentech, Roche's subsidiary, plans to invest about $750 million in an expansion to strengthen its drug production capacity in the United States. Exclusive material for subscribers. To have full access, access the material link and register.
Hastings Tribune
Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Aug 20, 2026-
Genentech Plans $750M Injectable Drug Manufacturing Facility in Hillsboro, Oregon
A new $750 million manufacturing facility in Hillsboro, Oregon, will expand U.S. production capacity for injectable medicines and advanced drug-delivery devices, with construction expected to create about 200 jobs before the project enters commercial operations in 2031. The planned facility will occupy part of a 75-acre campus in Hillsboro and add device fill-finish capabilities to […] The post Genentech Plans $750M Injectable Drug Manufacturing…
Genentech Plans $750 Million Hillsboro Manufacturing Expansion for Drug Delivery Devices
Genentech plans to invest approximately $750 million in a new manufacturing facility at its Hillsboro, Oregon, campus, adding device fill-finish capacity for pre-filled syringes, autoinjectors and other advanced drug delivery systems as the biotechnology company expands its U.S. production network. The project is expected to create 250 high-wage manufacturing jobs and approximately 200 construction jobs during development, with commercial operat…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
